Thu, August 11, 2022
Wed, August 10, 2022
Tue, August 9, 2022
Mon, August 8, 2022

Larry Biegelsen Downgraded (TNDM) to Sell and Decreased Target to $49 on, Aug 9th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-49-on-aug-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Larry Biegelsen of Wells Fargo, Downgraded "Tandem Diabetes Care, Inc." (TNDM) to Sell and Decreased Target from $82 to $49 on, Aug 9th, 2022.

Larry has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 1 agrees with Larry's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $110 on, Thursday, May 5th, 2022


These are the ratings of the 4 analyists that currently disagree with Larry


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Thursday, August 4th, 2022
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $82 on, Thursday, August 4th, 2022
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $80 on, Thursday, August 4th, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $130 on, Tuesday, May 17th, 2022